{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:12:06Z","timestamp":1758935526892},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2004,6,1]]},"DOI":"10.1532\/ijh97.03173","type":"journal-article","created":{"date-parts":[[2004,7,12]],"date-time":"2004-07-12T18:23:28Z","timestamp":1089656608000},"page":"465-471","source":"Crossref","is-referenced-by-count":9,"title":["Primary Mediastinal Large B-Cell Lymphoma: A Single-Institution Clinical Study in Japan"],"prefix":"10.1007","volume":"79","author":[{"given":"Naohiro","family":"Sekiguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Asamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensei","family":"Tobinai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","author":"Harris, NL","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood. 1994;84:1361-1392.","journal-title":"Blood"},{"key":"E00002","first-page":"175","author":"Banks, PM","year":"2001","unstructured":"Banks PM, Warnke RA. Mediastinal (thymic) large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology & Genetics:Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:175-176."},{"key":"E00003","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.1997.15.4.1646","volume":"15","author":"Lazzarino, M","year":"1997","unstructured":"Lazzarino M, Orlandi E, Paulli M, et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol. 1997;15: 1646-1653.","journal-title":"J Clin Oncol"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","volume":"20","author":"Cazals-Hatem","year":"1996","unstructured":"Cazals-Hatem D, Lepage E, Brice P, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 141 cases compared 916 nonmediastinal large B-cell lymphomas: a GELA (\"Groupe d'Etude des lymphomas de I'Adulte\") study. Am J Surg Pathol. 1996;20:877-888.","journal-title":"Am J Surg Pathol"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1200\/JCO.2001.19.6.1855","author":"Besien, KV","year":"2001","unstructured":"Besien KV, Kelta M, Bahaguna P. Primary mediastinal B-cell lymphoma: a review of pathology and management. J Clin Oncol. 2001; 19:1855-1864.","journal-title":"J Clin Oncol"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2141.1995.tb08415.x","volume":"89","author":"Falini, B","year":"1995","unstructured":"Falini B, Venturi S, Martelli M, et al. Mediastinal large B-cell lymphoma: clinical and immunohistologic findings in 18 patients treated with different third-generation regimens. Br J Haematol. 1995;89:780-789.","journal-title":"Br J Haematol"},{"key":"E00007","first-page":"1258","volume":"87","author":"Zinzani, PL","year":"2002","unstructured":"Zinzani PL, Martelli M, Bertini M, et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica. 2002;87:1258-1264.","journal-title":"Haematologica"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V94.10.3289.422k32_3289_3293","volume":"94","author":"Zinzani, PL","year":"1999","unstructured":"Zinzani PL, Martelli M, Magagnoli M, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67) gallium scan in 50 patients. Blood. 1999;94:3289-3293.","journal-title":"Blood"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/10428199909145713","author":"Bieri, S","year":"1999","unstructured":"Bieri S, Roggero E, Zucca E, et al. Primary mediastinal large B-cell lymphoma (PMLCL): the need for prospective controlled clinical trials. Leuk Lymphoma. 1999;35:139-146.","journal-title":"Leuk Lymphoma"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000421-198910000-00013","author":"Haioun, C","year":"1989","unstructured":"Haioun C, Gaulard P, Roudot-Thoraval F, et al. Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis. Am J Clin Oncol. 1989;12:425-429.","journal-title":"Am J Clin Oncol"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/1097-0142(19881101)62:9<1893::AID-CNCR2820620904>3.0.CO;2-X","author":"Jacobson, JO","year":"1988","unstructured":"Jacobson JO,Aisenberg AC, Lamarre L, et al. Mediastinal large cell lymphoma. an uncommon subset of adult lymphoma curable with combined modality therapy. Cancer. 1988;62:1893-1898.","journal-title":"Cancer"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1200\/JCO.1993.11.7.1336","volume":"11","author":"Kirn, D","year":"1993","unstructured":"Kirn D, Mauch P, Shaffer K, et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol. 1993;11:1336-1343.","journal-title":"J Clin Oncol"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1200\/JCO.1999.17.3.784","volume":"17","author":"Abou-Elella, AA","year":"1999","unstructured":"Abou-Elella AA, Weisenburger DD, Vose JM, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol. 1999;17:784-790.","journal-title":"J Clin Oncol"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF02982002","author":"Yonetani, N","year":"2001","unstructured":"Yonetani N, Kurata M, Nishikori M, et al. Primary mediastinal large B-cell lymphoma: a comparative study with nodular sclerosis-type Hodgkin's disease. Int J Hematol. 2001;74:178-185.","journal-title":"Int J Hematol"},{"key":"E00015","first-page":"44","author":"Nakagawa, A","year":"1993","unstructured":"Nakagawa A, Nakamura S, Koshikawa T, et al. Clinicopathologic study of primary mediastinal non-lymphoblastic non-Hodgkin's lymphomas among the Japanese. Acta Pathol Jpn. 1993;43:44-54.","journal-title":"Acta Pathol Jpn"},{"key":"E00016","first-page":"311","author":"Itami, J","year":"2002","unstructured":"Itami J, Hara R, Komiyama T, et al. Role of radiation therapy in the management of primary mediastinal large B-cell lymphoma (PMLBL). Rad Med. 2002;20:311-318.","journal-title":"Rad Med"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","author":"Rosenwald, A","year":"2003","unstructured":"Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851-862.","journal-title":"J Exp Med"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","author":"Savage, KJ","year":"2003","unstructured":"Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871-3879.","journal-title":"Blood"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02982638","author":"Lossos, IS","year":"2003","unstructured":"Lossos IS, Levy R. Diffuse large B-cell lymphoma: insights gained from gene expression profiling. Int J Hematol. 2003;77:321-329.","journal-title":"Int J Hematol"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0046-8177(83)80299-8","volume":"14","author":"Kadin, ME","year":"1983","unstructured":"Kadin ME, Berard CW, Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries: proceedings of the United States-Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol. 1983;14:745-772.","journal-title":"Hum Pathol"},{"key":"E00021","first-page":"987","author":"International Non-Hodgkin's Lymphoma Prognostic Factors, Project","year":"1993","unstructured":"International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.","journal-title":"N Engl J Med"},{"key":"E00022","first-page":"987","author":"International Non-Hodgkin's Lymphoma Prognostic Factors, Project","year":"1993","unstructured":"Green FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002:393-403.","journal-title":"N Engl J Med"},{"key":"E00023","first-page":"1860","author":"Carbone, PP","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971; 31:1860-1861.","journal-title":"Cancer Res"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","author":"Oken, MM","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-655.","journal-title":"Am J Clin Oncol"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","author":"Lister, TA","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB, et al. Report of committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds Meeting. J Clin Oncol. 1989;7: 1630-1636.","journal-title":"J Clin Oncol"},{"key":"E00026","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1200\/JCO.1988.6.1.128","author":"Shimoyama, M","year":"1988","unstructured":"Shimoyama M, Ota K, Kikuchi M, et al. Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J Clin Oncol. 1988;6: 128-141.","journal-title":"J Clin Oncol"},{"key":"E00027","first-page":"378","volume":"13","author":"Tobinai, K","year":"1994","unstructured":"Tobinai K, Shimoyama M, Minato K, et al. Japan Clinical Oncology Group phase II trial of second-generation \"LSG4 protocol\" in aggressive T- and B-lymphoma: a new predictive model for T- and B-lymphoma [abstract]. Proc Am Soc Clin Oncol. 1994;13:378.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"E00028","first-page":"289a","volume":"21","author":"Kinoshita","year":"2002","unstructured":"Kinoshita T, Hotta T, Tobinai K, et al. Randomized phase III trial investigating survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma (NHL): Japan Clinical Oncology Group (JCOG) Study (JCOG9002) [abstract]. Proc Am Soc Clin Oncol. 2002;21:289a.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"E00029","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00000478-198909000-00002","volume":"13","author":"Lamarre, L","year":"1989","unstructured":"Lamarre L, Jacobson JO, Aisenberg AC, Harris NL. Primary large cell lymphoma of the mediastinum: a histologic and immunophenotypic study of 29 cases. Am J Surg Pathol. 1989;13: 730-739.","journal-title":"Am J Surg Pathol"},{"key":"E00030","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","author":"Non-Hodgkin's Lymphoma Classification, Project","year":"1997","unstructured":"Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.","journal-title":"Blood"},{"key":"E00031","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","author":"Armitage, JO","year":"1998","unstructured":"Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes: Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998;16:2780-2795.","journal-title":"J Clin Oncol"},{"key":"E00032","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","author":"Anderson, JR","year":"1998","unstructured":"Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol. 1998;9:717-720.","journal-title":"Ann Oncol"},{"key":"E00033","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1096-911X(199808)31:2<125::AID-MPO17>3.0.CO;2-M","author":"Toh, HC","year":"1998","unstructured":"Toh HC, Koh CH, Ang PT. Primary mediastinal large cell lymphoma in an aggressive and chemorefractory subtype in an Asian diffuse large cell lymphoma series. Med Pediatr Oncol. 1998;31:125.","journal-title":"Med Pediatr Oncol"},{"key":"E00034","first-page":"696","author":"Lymphoma Study Group of Japanese, Pathologists","year":"2000","unstructured":"Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000;50: 696-702.","journal-title":"Pathol Int"},{"key":"E00035","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-102-5-596","author":"Klimo, P","year":"1985","unstructured":"Klimo P, Connors JM. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med. 1985;102: 596-602.","journal-title":"Ann Intern Med"},{"key":"E00036","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood.V91.2.717","author":"Sehn, LH","year":"1998","unstructured":"Sehn LH,Antin JH, Shulman LN, et al. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood. 1998;91:717-723.","journal-title":"Blood"},{"key":"E00037","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.1998.16.1.63","author":"Popat, U","year":"1998","unstructured":"Popat U, Przepiorka D, Champlin R, et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts a favorable prognosis. J Clin Oncol. 1998;16:63-69.","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.03173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T18:19:54Z","timestamp":1585851594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.03173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,1]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,6,1]]}},"alternative-id":["X9WFLQJ4G34JJMQE"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.03173","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6,1]]}}}